Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell CarcinomaNoriaki Arakawa, Etsuko Miyagi|PLoS ONE|2016Cited by 38
Stratifin as a novel diagnostic biomarker in serum for diffuse alveolar damageNoriaki Arakawa, Masayuki Hanaoka|Nature Communications|2022Cited by 29
Stratifin as a Novel Diagnostic Biomarker in Serum for Diffuse Alveolar DamageNoriaki Arakawa, Masayuki Hanaoka|Research Square|2021Cited by 1